Navigation Links
Scientists identify new gene responsible for puberty disorders
Date:10/27/2008

AUGUSTA, Ga. A new gene responsible for some puberty disorders has been identified by Medical College of Georgia researchers.

They found that the gene mutated in CHARGE syndrome a multi-system disorder characterized by diverse problems from heart defects to hearing loss to cleft lip and palate and mental retardation also accounts for about 6 percent of two puberty disorders. These disorders idiopathic hypogonadotropic hypogonadism, or IHH, and Kallmann syndrome short circuit puberty and can cause infertility. Kallmann syndrome is also marked by patients' inability to smell.

Dr. Lawrence Layman, chief of the MCG Section of Reproductive Endocrinology, Infertility and Genetics in the School of Medicine, and colleagues published an article in the October issue of The American Journal of Human Genetics linking the diseases.

CHARGE syndrome can also impair the sense of smell and inhibit production of sex steroids and hormones, so researchers suspected a common gene.

"Thinking that IHH and Kallmann syndrome could represent a milder version of CHARGE Syndrome, we set out to study the gene in a large sample of patients diagnosed with delayed puberty but not CHARGE," Dr. Layman says.

The identified gene is called chromodomain helicase DNA binding protein 7, or CHD7. In 101 people with IHH and Kallmann syndrome, researchers found seven mutations of CHD7 that weren't present in nearly 200 healthy individuals.

"This suggests that they were mutations causing the disorder, and we also showed that most of these mutations impaired the gene's function," Dr. Layman says.

Typically, puberty begins around age 10 in boys and age 8 or 9 in girls. It starts when the hypothalamus in the brain releases more gonadotropin releasing hormone, or GnRH, which stimulates the pituitary gland to make puberty-related hormones. This prompts ovaries to produce estrogen and eggs and testes to produce testosterone and sperm.

Pubertal disorders, Dr. Layman says, often begin long before that chain of events begins.

He traces the defects to gestation, when neurons linked to reproduction and sense of smell fail to reach their destination together.

"While the discovery of additional genes involved in pubertal disorders is significant, we only know the cause for about one-third of all affected patients," says Hyung-Goo Kim, molecular geneticist in the Institute of Molecular Medicine and Genetics and the study's first author. "We know now that CHD7, only the second gene identified as a cause for IHH and Kallmann Syndrome, is a common culprit."

"There is still work to be done," says Dr. Layman, corresponding author. "But this work is important because it gives us cause for genetic counseling on patients with these mutations. And because these findings suggest that IHH and Kallmann Syndrome are mild variants of CHARGE, it also prompts us to look more carefully for heart problems, hearing loss and cleft lip/palate in patients with pubertal abnormalities."


'/>"/>

Contact: Jennifer Hilliard
jhilliard@mcg.edu
706-721-8604
Medical College of Georgia
Source:Eurekalert  

Related medicine news :

1. Gladstone scientists identify role of fatty acids in Alzheimers disease
2. Scientists Hot on Trail of New Antibiotics
3. Scientists close in on method to fight deadly childhood cancer
4. NIH scientists discover crucial control in long-lasting immunity
5. New Site Launched for Families and Scientists to Discuss Stem Cell Research (US)
6. 2 UCSF scientists recognized for transformative research
7. Scientists take cancer research back to the basic molecular level
8. Rice political scientists co-author report on ethnic/racial aspects of Taser use by Houston police
9. Scientists produce nanoscale droplets with cancer-fighting implications
10. Scientists find second site for prostate cancer gene
11. Scientists Track Hourly Changes in Alzheimers Protein
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists identify new gene responsible for puberty disorders
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A ... minister and college Bible teacher residing in North Carolina with his wife, Anna Marie. ... blessed them with six grandchildren. David is also the author of “Shadow and Substance.” ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World Health Organization declared the ... four million Zika-related cases in the Americas within the next year. Lyme disease is ... per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating their ... 16 more public health departments have been awarded national accreditation through the ... people into the expanding network of communities across the nation whose health departments ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) ... are making a huge impact on businesses and individual consumers alike. Laboratories can ... will have a value anywhere from $4 trillion to $11 trillion dollars by the ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017  Additive Orthopaedics, LLC., ... that it has kicked off a multi-centered clinical ... printed bone segments. According to ... variable honeycomb lattice structures have already shown tremendous ... to current allograft wedges from which we have ...
(Date:3/23/2017)... Denmark , March 23, 2017 Ascendis ... its innovative TransCon technology to address significant unmet medical ... will host a conference call and webcast on Monday, ... the Endocrine Society in Orlando, Florida ... disease pipeline candidates (TransCon Growth Hormone, TransCon PTH and ...
(Date:3/23/2017)... 23, 2017 Prima BioMed has ... trial of IMP321 in combination with Keytruda, with one ... cohort experiencing a complete response. Recruitment in the second ... to be fully recruited by Q317. Preliminary efficacy data ... cancer study are expected mid-year (recruitment in the 226-patient ...
Breaking Medicine Technology: